Literature DB >> 9831541

The inhibition of the estrogenic effects of pesticides and environmental chemicals by curcumin and isoflavonoids.

S P Verma1, B R Goldin, P S Lin.   

Abstract

Many environmental chemicals and pesticides have been found to be estrogenic and have been shown to stimulate the growth of estrogen receptor-positive (ER-positive) human breast cancer cells. Since it is difficult to avoid human exposure to environmental estrogens, a potentially important area of research is the development of dietary strategies to prevent the stimulated growth of breast tumors by environmental estrogens. In this context, the inhibitory action of curcumin and a combination of curcumin and isoflavonoids were studied in ER-positive human breast cancer cells (MCF-7 and T47D) and ER-negative MDA-MB-231 cells induced by the pesticide o,p'-DDT and the environmental pollutants 4-nonylphenol and 4-octylphenol. The median inhibitory concentration (IC50) for curcumin in T47D cells was 10 microM when measured at either a 48-hr or a 6-day incubation time. The IC50 value for curcumin was within the 8-10 microM range for inhibiting the growth of T47D cells induced by a 10- microM concentration each of 4-nonylphenol, 4-octylphenol, and o, p'-DDT. The IC50 for curcumin in MCF-7 cells induced by 10 microM of either o,p'-DDT, 4-octylphenol, or 4-nonylphenol were 9, 39, and >50 microM, respectively. A combination of curcumin and isoflavonoids was able to inhibit the induced growth of ER-positive cells up to 95%. For MDA-MB-231 cells, the IC50 for curcumin was 17 microM, which was reduced to 11 microM in the presence of 25 microM genistein. Curcumin and genistein induce drastic changes in the morphological shape of both ER-positive and ER-negative cells. Data presented here indicate that a mixture of curcumin and isoflavonoids is the most potent inhibitor against the growth of human breast tumor cells. These data suggest that combinations of natural plant compounds may have preventive and therapeutic applications against the growth of breast tumors induced by environmental estrogens.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9831541      PMCID: PMC1533252          DOI: 10.1289/ehp.106-1533252

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  32 in total

1.  Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease.

Authors:  A Mazumder; S Wang; N Neamati; M Nicklaus; S Sunder; J Chen; G W Milne; W G Rice; T R Burke; Y Pommier
Journal:  J Med Chem       Date:  1996-06-21       Impact factor: 7.446

2.  Inhibition of proliferation of estrogen receptor-positive MCF-7 human breast cancer cells by flavonoids in the presence and absence of excess estrogen.

Authors:  F V So; N Guthrie; A F Chambers; K K Carroll
Journal:  Cancer Lett       Date:  1997-01-30       Impact factor: 8.679

3.  Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third-generation aromatase inhibitor vorozole.

Authors:  P C de Jong; J van de Ven; H W Nortier; I Maitimu-Smeele; T H Donker; J H Thijssen; P H Slee; R A Blankenstein
Journal:  Cancer Res       Date:  1997-06-01       Impact factor: 12.701

4.  Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion.

Authors:  H S Samaha; G J Kelloff; V Steele; C V Rao; B S Reddy
Journal:  Cancer Res       Date:  1997-04-01       Impact factor: 12.701

5.  Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis.

Authors:  T Fotsis; M S Pepper; E Aktas; S Breit; S Rasku; H Adlercreutz; K Wähälä; R Montesano; L Schweigerer
Journal:  Cancer Res       Date:  1997-07-15       Impact factor: 12.701

6.  Curcumin and genistein, plant natural products, show synergistic inhibitory effects on the growth of human breast cancer MCF-7 cells induced by estrogenic pesticides.

Authors:  S P Verma; E Salamone; B Goldin
Journal:  Biochem Biophys Res Commun       Date:  1997-04-28       Impact factor: 3.575

Review 7.  Environment and cancer: who are susceptible?

Authors:  F P Perera
Journal:  Science       Date:  1997-11-07       Impact factor: 47.728

8.  Effect of soy-derived isoflavonoids on the induced growth of MCF-7 cells by estrogenic environmental chemicals.

Authors:  S P Verma; B R Goldin
Journal:  Nutr Cancer       Date:  1998       Impact factor: 2.900

9.  Effects of curcumin, demethoxycurcumin, bisdemethoxycurcumin and tetrahydrocurcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion.

Authors:  M T Huang; W Ma; Y P Lu; R L Chang; C Fisher; P S Manchand; H L Newmark; A H Conney
Journal:  Carcinogenesis       Date:  1995-10       Impact factor: 4.944

Review 10.  Phytoestrogens: epidemiology and a possible role in cancer protection.

Authors:  H Adlercreutz
Journal:  Environ Health Perspect       Date:  1995-10       Impact factor: 9.031

View more
  15 in total

1.  Combined effect of xenoestrogens and growth factors in two estrogen-responsive cell lines.

Authors:  Louis J Cossette; Isabelle Gaumond; Maria-Grazia Martinoli
Journal:  Endocrine       Date:  2002-08       Impact factor: 3.633

Review 2.  Cancer stem cells and cancer therapy.

Authors:  Sara Soltanian; Maryam M Matin
Journal:  Tumour Biol       Date:  2011-02-12

Review 3.  The targets of curcumin.

Authors:  Hongyu Zhou; Christopher S Beevers; Shile Huang
Journal:  Curr Drug Targets       Date:  2011-03-01       Impact factor: 3.465

4.  Curcumin delays development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors.

Authors:  Candace E Carroll; Indira Benakanakere; Cynthia Besch-Williford; Mark R Ellersieck; Salman M Hyder
Journal:  Menopause       Date:  2010 Jan-Feb       Impact factor: 2.953

5.  Toxicity of seven phthalate esters to embryonic development of the abalone Haliotis diversicolor supertexta.

Authors:  Ying Liu; Yuntao Guan; Zhihui Yang; Zhonghua Cai; Tadao Mizuno; Hiroshi Tsuno; Wapeng Zhu; Xihui Zhang
Journal:  Ecotoxicology       Date:  2008-11-22       Impact factor: 2.823

6.  Cancer-linked targets modulated by curcumin.

Authors:  Noor Hasima; Bharat B Aggarwal
Journal:  Int J Biochem Mol Biol       Date:  2012-12-24

Review 7.  Curcumin: from ancient medicine to current clinical trials.

Authors:  H Hatcher; R Planalp; J Cho; F M Torti; S V Torti
Journal:  Cell Mol Life Sci       Date:  2008-06       Impact factor: 9.261

8.  Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells.

Authors:  Jyoti Nautiyal; Shailender S Kanwar; Yingjie Yu; Adhip Pn Majumdar
Journal:  J Mol Signal       Date:  2011-07-20

9.  Bisphenol-A-induced inactivation of the p53 axis underlying deregulation of proliferation kinetics, and cell death in non-malignant human breast epithelial cells.

Authors:  Shanaz H Dairkee; M Gloria Luciani-Torres; Dan H Moore; William H Goodson
Journal:  Carcinogenesis       Date:  2012-12-07       Impact factor: 4.944

10.  Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-κB and Src protein kinase signaling pathways.

Authors:  Mehdi Shakibaei; Ali Mobasheri; Cora Lueders; Franziska Busch; Paviz Shayan; Ajay Goel
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.